Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-23

Clinical Trial Update: Roux-en-Y Gastric Bypass for BMI 27-32 Type 2 Diabetes Versus Best Medical Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Roux-en-Y gastric bypass to best medical treatment in type 2 diabetes patients with BMI 27-32 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Roux-en-Y gastric bypass

Snippet

Sponsor: Khoo Teck Puat Hospital | Conditions: Type II Diabetes in Subjects BMI 27 to 32 | Phase 4 | Status: COMPLETED